Premarket Movers Oct 27, 2026: Why BRAI, NEXR, MFIC Are Up

BRAI — Braiin Ltd (+43.2%)

Braiin is up 43.2% to $3.15 in premarket trading. About 5.4 million shares have changed hands, versus a 20-day average of roughly 525,000 for a full day. Premarket volume is already around ten times a normal session.

The likely catalyst is a GlobeNewswire release dated October 26 announcing Force AI. It is a unified AI orchestration layer for Braiin's RADIUS contact-center platform. It works with any major large language model, so customers avoid vendor lock-in. Benzinga reported the stock up 36.8% to $2.90 earlier in premarket trading. The news came out a day early, and the stock reversed sharply on October 26. MarketScreener showed it finishing that session down 40.28% at $2.12. This premarket jump is therefore a partial rebound from a steep drop.

The prior-day setup is weak. The stock sits 93.3% below its 52-week high, with a conviction score of 36/100 (grade D), RSI 14 and ADX 27. It is gapping up 21.7%.

The squeeze data is the unusual part. Free float, the share of stock actually available to trade, is only 0.7%. Short interest is 124,597 shares, or 3.2 days to cover, and the squeeze score is 73/100. A short-sale restriction (SSR) is active. Thin floats like this can swing violently in both directions.

NEXR — Nexera Technologies Ltd (+34.6%)

Nexera is up 34.6% to $0.60 on about 43.7 million shares. Its 20-day average is about 785,000, so volume is far above normal. Market cap is only $2.8M.

The catalyst isn't confirmed. Nexera announced on October 27 that it will sell its KeepZone AI unit to an unnamed aerospace and defense buyer. The price is $1 million in the buyer's securities, plus an earn-out of up to $5 million based on KeepZone's profits over 24 months. No source ties the sale to the price move. One quote page also showed the stock down about 9% when captured, so the picture is mixed.

The prior-day setup is deeply damaged. The stock is 98.5% below its 52-wk high, with RSI 20, ADX 20, conviction 45/100 (grade D) and a prior gap of -8.7%. Free float is 99.1%, short interest is 87,756 shares (0.2 days to cover), and the squeeze score is a low 28/100. This does not look like a squeeze. Sub-$1 micro-caps like this can move sharply either way.

MFIC — MidCap Financial Investment Corp (+20.9%)

MidCap Financial is up 20.9% to $10.10 on about 693,000 shares. That is already above its 20-day average of about 558,000.

The reason is a buyout. On October 27, Ares Capital (ARCC) agreed to acquire MFIC in a deal worth about $2.6 billion in total enterprise value, paid partly in cash and partly in stock. The offer is $10.88 per share: about $1.21 in cash and roughly $9.67 in ARCC stock. Investing.com calls that a 30.1% premium to the prior close. The deal has not closed, and the target is the first half of 2027. Because part of the price is paid in ARCC stock, the offer's value moves with ARCC. The stock trading below $10.88 reflects that and the time and risk before closing.

The prior-day chart was bearish. The pattern was a downtrend with a bearish MA stack, RSI 39, RS rating 17 and a trend-template score of 0. It was flagged in the retest lane. Short interest is 2,769,632 shares (5.1 days to cover), squeeze score 35/100. This is a deal-driven move, not a technical breakout.

CLRO — CLEARONE INC (+20.1%)

ClearOne is up 20.1% to $5.98 on about 13.7 million shares, roughly double its 20-day average of 7.0 million. Market cap is $13.3M. The stock is gapping up 33.5%. We covered it in our Oct 26 premarket recap and Oct 26 top movers.

No news, filing or announcement fresh today explains the move. Coverage from October 26 describes speculators revisiting the Cortigent deal despite delisting risk. SEC filings show an October 15 8-K on an agreement (neutral) and an October 13 8-K on delisting (bearish). The move looks momentum-driven.

Technically, RSI is 60, ADX 23, the MA stack is mixed, and the stock is 69.8% below its 52-week high. RS rating is 54, trend-template score is 3, and conviction is only 8/100 (grade D). Free float is 32.7%, short interest 24,903 shares (0.5 days to cover), squeeze score 38/100. The largest disclosed stake is 61.3%. A delisting overhang adds risk.

SOFX — Defiance Daily Target 2X Long SOFI ETF (+20.0%)

SOFX is up 20.0% to $6.81 on about 2.6 million shares, versus a 20-day average of about 1.5 million.

The likely catalyst is SoFi Technologies' Q3 2026 earnings, released before the open. Reuters reported record adjusted net revenue of $1.4 billion against $1.25 billion expected, and adjusted profit of 18 cents per share versus 16 cents expected. Membership reached 17.1 million. SoFi raised its full-year 2026 revenue outlook to $5.04 billion, according to Rolling Out. SOFX is a 2x daily leveraged fund on SOFI, so it tracks SoFi's move at about double the size. Finviz showed SOFX up about 23% and SOFI up about 11% at 8:42 AM ET.

Leveraged ETFs reset daily and can lose value fast when the underlying stock reverses. The prior-day setup was bearish: the stock was 89.8% below its 52-wk high, RSI 35, ADX 27, bearish MA stack and RS rating 4. Short interest is 2,438,728 shares (2.3 days to cover), squeeze score 54/100.

The bottom line

Premarket gains come on thin volume and can vanish at the 9:30 AM ET open. Several of these are micro-caps, low-float stocks or a leveraged fund. Chasing extended gainers is high-risk, patterns and squeezes fail often, and nothing here suggests the moves continue. Use defined risk, and do your own research. See our guide on where to place a stop loss. This is educational content, not financial advice.

StockSetups scans the full US stock universe after every close and every premarket morning, so you can see the setups behind the movers.